Peters Medical Research

The trials here

What the 15 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis4 trials
• Gastroparesis2 trials
• Migraine2 trials
• Atrial fibrillation1 trial
• COPD1 trial
• Crohn's disease1 trial
• Familial hypercholesterolaemia1 trial
• High blood pressure1 trial
• Irritable bowel syndrome1 trial
• Lung cancer1 trial
• Stroke1 trial

Phase

• Phase 28 trials
• Phase 34 trials
• Phase 11 trial
• Phase 1/21 trial

Status

• Recruiting5 trials
• Completed4 trials
• Active, not recruiting3 trials
• Terminated3 trials

Lead sponsor

• CinDome Pharma, Inc.2 trials
• CRISPR Therapeutics AG2 trials
• TriGemX Bio, Inc.2 trials
• CinPhloro Pharma, LLC1 trial
• Cristcot HCA LLC1 trial
• and 7 more

Running trials

• Recruiting

  A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension

  NCT07758634· Phase 1/2· CRISPR Therapeutics AG· Source

  Contact: Clinical Trials

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  Confirmatory Clinical Study in Active Ulcerative Colitis

  NCT07296315· Phase 2· MRM Health NV· Source

  Contact: Roy Peters

• Active, not recruiting

  A Study to Evaluate Solrikitug in Participants With COPD (ZION)

  NCT06496620· Phase 2· Uniquity One (UNI)· Source

• Recruiting

  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  NCT06226883· Phase 2· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Source

  Contact: Roy Peters (principal investigator)

• Recruiting

  A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

  NCT07491172· Phase 1· CRISPR Therapeutics AG· Source

  Contact: Erika Jordan

• Active, not recruiting

  A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05528510· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Screening for High Frequency Malignant Disease

  NCT05117840· Guardant Health, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Crohn's disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• High blood pressure1 recruiting
• Stroke1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Terminated

  A Study of K-645 in the Treatment of Multiple Migraine Attacks

  NCT07116499· Phase 2· TriGemX Bio, Inc.· Source

• Completed

  A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

  NCT06848075· Phase 2· TriGemX Bio, Inc.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

  NCT06899217· Phase 2· CinDome Pharma, Inc.· Source

• Terminated

  Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

  NCT06153420· Phase 2· CinPhloro Pharma, LLC· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

  NCT05832151· Phase 2· CinDome Pharma, Inc.· Source

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source

• Completed

  Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

  NCT04469686· Phase 3· Cristcot HCA LLC· Source